Hologic, Inc.

Total Valuation

Hologic, Inc. carries a market capitalization of 16.97B, placing it among publicly traded companies globally. Its enterprise value stands at 16.89B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Hologic, Inc. currently has 223.07M shares outstanding.

Valuation Ratios

Hologic, Inc. trades at a trailing price-to-earnings ratio of 30.78. The price-to-sales ratio is 4.06, and the price-to-book ratio stands at 4.66.

Enterprise Valuation

On an enterprise value basis, Hologic, Inc. trades at an EV/EBITDA multiple of 15.53 and an EV/FCF ratio of 13.25. The EV/Sales ratio of 4.09 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.31 provides insight into valuation relative to core operating earnings.

Financial Position

Hologic, Inc. maintains a current ratio of 4.04, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 48.05, indicating elevated leverage, while an interest coverage ratio of 9.53 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Hologic, Inc. posts a return on equity of 16.37 and a return on invested capital of 8.66.

Taxes

Over the trailing twelve months, Hologic, Inc. has paid 119.60M in income taxes, reflecting an effective tax rate of 18.03.

Stock Price Statistics

Hologic, Inc.'s stock has gained approximately 37.12791% over the past 52 weeks. The 50-day moving average sits at 75.29, while the 200-day moving average is 71.28.

Income Statement

Over the trailing twelve months, Hologic, Inc. generated 4.13B in revenue and converted that into 543.80M in net income, yielding earnings per share of 2.41. EBITDA reached 1.09B, while operating income came in at 792.60M.

Balance Sheet

Hologic, Inc. holds 2.36B in cash and equivalents against 2.52B in total debt, resulting in a net debt position of 340.70M. Total book value stands at 3.59B, with working capital of 2.89B providing operational flexibility.

Cash Flow

Hologic, Inc. produced 1.10B in operating cash flow over the past twelve months. After subtracting -83.80M in capital expenditures, free cash flow totaled 1.01B - equivalent to 4.51 per share.

Margins

Hologic, Inc. operates with a gross margin of 51.47, reflecting its pricing power and cost economics. The operating margin of 19.21 and net profit margin of 13.18 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Hologic, Inc.'s most recent stock split took place on April 3, 2008 with a 1:2 split ratio.

Scores

Hologic, Inc. posts an Altman Z-Score of 5.61, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.